Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Cancer Discovery|June 9, 2018
MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal TumorsAnuratha Sakthianandeswaren, Marie J Parsons, Dmitri Mouradov, et al.Immunity|March 22, 2018
Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent MannerLorraine A O'Reilly, Tracy L Putoczki, Lisa A Mielke, et al.Cancer Cell|August 17, 2013
Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeuticallyTracy L Putoczki, Stefan Thiem, Andrea Loving, et al.Science (New York, N.Y.)|July 3, 2025
Relative importance of the anti-apoptotic versus apoptosis-unrelated functions of MCL-1 in vivoKerstin Brinkmann, Kate McArthur, Shezlie Malelang, et al.The Journal of Experimental Medicine|May 31, 2019
TCF-1 limits the formation of Tc17 cells via repression of the MAF-RORγt axisLisa A Mielke, Yang Liao, Ella Bridie Clemens, et al.Cell Death and Differentiation|July 13, 2019
Loss of Bcl-G, a Bcl-2 family member, augments the development of inflammation-associated colorectal cancerPaul M Nguyen, Laura F Dagley, Adele Preaudet, et al.The Journal of Allergy and Clinical Immunology|March 27, 2021
Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndromeYin-Huai Chen, Diane B Zastrow, Riley D Metcalfe, et al.Nature Communications|September 15, 2018
NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel diseaseHazel Tye, Chien-Hsiung Yu, Lisa A Simms, et al.Nature Communications|April 3, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVIDStefanie M Bader, Dale J Calleja, Shane M Devine, et al.Pageof 6